Trial intelligence / Profile preview

Opiorphin Levels in Burning Mouth Syndrome (OPIODYN)

NCT02686359Completed

Sponsor
Assistance publique - Hôpitaux de Paris
Start
Jul 2011
Primary completion
Dec 2012
01

Overview

Single-blind trial (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Opiorphin levels in saliva at Day 30. Started Jul 2011; status: completed.

Beyond the preview

Go deeper on NCT02686359.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02686359.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call